Pediatrix Medical Group, Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Pediatrix Medical Group, Inc. filed 4 open-market sales worth $1.8 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Weis Shirley A, Director, sold 36,028 shares at $23.75 on 13 May 2026, filed 14 May 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 13 May 2026 | Weis Shirley A | Director | Sale | 36,028 | $23.75 | $855,665 | Form 4 |
| 15 December 2025 | Ordan Mark S | Chief Executive Officer | Sale | 23,000 | $22.41 | $515,430 | Form 4 |
| 17 November 2025 | Rucker Michael A. | Director | Sale | 10,478 | $23.00 | $240,994 | Form 4 |
| 6 November 2025 | Linynsky Laura A | Director | Sale | 10,000 | $21.65 | $216,500 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Pediatrix Medical Group, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.